Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signaling

Rina Kanda, Akihiko Kawahara, Kosuke Watari, Yuichi Murakami, Kahori Sonoda, Masashi Maeda, Hideaki Fujita, Masayoshi Kage, Hidetaka Uramoto, Carlota Costa, Michihiko Kuwano, Mayumi Ono

Research output: Contribution to journalArticlepeer-review

121 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signaling'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology